Saturday, 12 November 2016

J&J arthritis drug goes up against Humira, with mixed results

(Reuters) - Johnson & Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc's top-selling Humira in a large trial.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)